参考文献
[1] ESMO Immuno-Oncology Congress 2023. 167P - Lurbinectedin, a DNA minor
groove inhibitor launches a multimodal immune response through activation of
the cytosolic DNA-Sensing cGAS-STING pathway. (2023-12-06)[2024-01-03]. https://cslide.ctimeetingtech.com/immuno23hybrid/attendee/confcal/presentation/list?q=lurbinectedin
[2] LIU C, ZHOU Y, GUO D, et al. Reshaping Intratumoral Mononuclear
Phagocytes with Antibody-Opsonized Immunometabolic Nanoparticles. Adv Sci
(Weinh). 2023 Dec, 10(34), e2303298.
[3] PARK S J, YE W, XIAO R, et al. Cisplatin and oxaliplatin induce
similar immunogenic changes in preclinical models of head and neck cancer. Oral
Oncol. 2019 Aug, 95:127-135.
[4] 胡晓,姜龙,王宝宝等.MHC分子与肿瘤免疫及治疗的研究进展[J].生命科学,2021,33(07):833-843.